SAM #36E79726R0013

This opportunity involves a large-scale procurement of Budesonide/Formoterol inhalers for federal healthcare systems: - Government Buyer: - Department of Veterans Affairs (VA) National Acquisition Center (NAC Pharmaceuticals, 36E797) - Supports VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC) - Products Requested: - Budesonide 160mcg/Formoterol Fumarate 4.5mcg per spray inhaler, oral, 10.2g canister - Estimated annual quantity: 722,021 canisters - Budesonide 80mcg/Formoterol Fumarate 4.5mcg per spray inhaler, oral, 10.2g canister - Estimated annual quantity: 220,295 canisters - Requirements: - Offerors must provide the exact product name as it appears on the drug label - Each product must have a unique National Drug Code (NDC) number - Distribution through VA and DoD Pharmaceutical Prime Vendor Programs - Open to all responsible sources able to supply the required inhalers; no specific OEMs or vendors named - Contract Structure: - One-year base contract with four pre-priced one-year option periods (potential total of five years) - Place of Performance/Delivery: - VA National Acquisition Center, Hines, IL - Department of Veterans Affairs National Acquisition Center, Chicago, IL

PRE-SOLICITATION NOTICE:  The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0013 for an unrestricted procurement for Budesonide/Formoterol INH, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).  VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.  Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79726R0013 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about March 30, 2026, with a tentative closing date of April 13, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Kenneth Lay. Questions can be e-mailed to Kenneth.Lay@va.gov.   The estimated annual requirements are as follows:  REQUIREMENT DESCRIPTION  ITEM  DESCRIPTION  PACKAGE SIZE (CANISTERS) TOTAL ESTIMATED ANNUAL USAGE (CANISTERS) 1 BUDESONIDE 160MCG/FORMOTEROL FUM 4.5MCG/SPRAY INHL,ORAL,10.2GM 1 722,021 2 BUDESONIDE 80MCG/FORMOTEROL FUM 4.5MCG/SPRAY INHL,ORAL,10.2GM 1 220,295